HTG Molecular Diagnostics

BiotechnologySeries DTucson, UShtgmolecular.com

Latest round

Series D

Last raised

Feb 2014

Total raised

$44M

Investors

11

About HTG Molecular Diagnostics

Founded in 1997 and based in Arizona, US, HTG Molecular Diagnostics, Inc. provides molecular technology solutions to develop assays and reagent systems used to detect changes in gene expression levels.

Who invested in HTG Molecular Diagnostics

11 investors across 7 rounds

See all investors in HTG Molecular Diagnostics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Feb 14, 2014

    Amount

    $7.6M

    Investors

    Locked

  2. Series D

    Nov 12, 2012

    Amount

    $7.6M

    Investors

    Locked

  3. Series D

    Jun 8, 2011

    Amount

    $4.4M

    Investors

    Locked

  4. Series D

    Feb 23, 2011

    Amount

    $10M

    Investors

    Locked

  5. Series C

    Sep 20, 2007

    Amount

    $10M

    Investors

    Locked

  6. Series B

    May 4, 2005

    Amount

    $3.4M

    Investors

    Locked

  7. Series A

    Jan 18, 2002

    Amount

    $1.3M

    Investors

    Locked

Questions about HTG Molecular Diagnostics

Who invested in HTG Molecular Diagnostics?

HTG Molecular Diagnostics has 11 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has HTG Molecular Diagnostics raised?

HTG Molecular Diagnostics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.

When did HTG Molecular Diagnostics last raise money?

HTG Molecular Diagnostics's most recent round on record is a Series D, in Feb 2014.

What does HTG Molecular Diagnostics do?

Founded in 1997 and based in Arizona, US, HTG Molecular Diagnostics, Inc.

Where is HTG Molecular Diagnostics headquartered?

HTG Molecular Diagnostics is headquartered in Tucson, US.

Which VCs invest in companies like HTG Molecular Diagnostics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at HTG Molecular Diagnostics's stage. Their profiles are linked below.

Raising like HTG Molecular Diagnostics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.